We are live on ! Find out more
NPT

Nixon Peabody Trust Portfolio holdings

AUM $1.41B
1-Year Est. Return 27.78%
This Fund
S&P 500
This Quarter Est. Return
+1.72%
1 Year Est. Return
+27.78%
3 Year Est. Return
+85.33%
5 Year Est. Return
+107.3%
10 Year Est. Return
+380.86%
AUM
$1.21B
AUM Growth
+$13.1M
Cap. Flow
+$8.6M
Cap. Flow %
0.71%
Top 10 Hldgs %
43.73%
Holding
152
New
13
Increased
73
Reduced
40
Closed
5

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$7.37M
2
LLY icon
Eli Lilly
LLY
+$6.73M
3
NOW icon
ServiceNow
NOW
+$6.52M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$6.42M
5
VRT icon
Vertiv
VRT
+$5.2M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$8.45M
2
ROP icon
Roper Technologies
ROP
+$8.39M
3
ROK icon
Rockwell Automation
ROK
+$7.79M
4
MDT icon
Medtronic
MDT
+$6.89M
5
CMCSA icon
Comcast
CMCSA
+$6.88M

Sector Composition

Rank Sector Weight
1 Technology 24.02%
2 Financials 10.78%
3 Industrials 9.93%
4 Healthcare 9.42%
5 Consumer Discretionary 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
51
Berkshire Hathaway Class B
BRK.B
$1.11T
$5.07M 0.42%
11,192
+534
+5% +$247K
VRT icon
52
Vertiv
VRT
$101B
$4.98M 0.41%
+43,793
New +$5.2M
ETN icon
53
Eaton
ETN
$170B
$4.8M 0.4%
14,467
+13,430
+1,295% +$4.71M
ELV icon
54
Elevance Health
ELV
$83B
$4.41M 0.36%
+11,959
New +$5M
DUK icon
55
Duke Energy
DUK
$96.9B
$4.37M 0.36%
40,550
+884
+2% +$100K
NVS icon
56
Novartis
NVS
$292B
$4.14M 0.34%
42,501
-79,269
-65% -$8.45M
MDT icon
57
Medtronic
MDT
$111B
$4.02M 0.33%
50,379
-79,560
-61% -$6.89M
VUG icon
58
Vanguard Morningstar Growth ETF
VUG
$225B
$3.86M 0.32%
56,400
SHY icon
59
iShares 1-3 Year Treasury Bond ETF
SHY
$25B
$3.59M 0.3%
43,736
+18,213
+71% +$1.5M
ROK icon
60
Rockwell Automation
ROK
$53.5B
$3.3M 0.27%
11,546
-27,710
-71% -$7.79M
IJR icon
61
iShares Core S&P Small-Cap ETF
IJR
$111B
$2.8M 0.23%
24,284
-233
-1% -$27.8K
ROP icon
62
Roper Technologies
ROP
$38.8B
$2.56M 0.21%
4,920
-15,283
-76% -$8.39M
CMCSA icon
63
Comcast
CMCSA
$87.2B
$2.48M 0.2%
66,197
-165,735
-71% -$6.88M
VGIT icon
64
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
$2.33M 0.19%
40,225
+17,623
+78% +$1.04M
IWM icon
65
iShares Russell 2000 ETF
IWM
$81.5B
$2.27M 0.19%
10,275
-600
-6% -$137K
ADP icon
66
Automatic Data Processing
ADP
$107B
$2.23M 0.18%
7,616
+187
+3% +$55.3K
AXP icon
67
American Express
AXP
$233B
$2.21M 0.18%
7,436
+132
+2% +$37.9K
ABT icon
68
Abbott
ABT
$185B
$2.13M 0.18%
18,873
+867
+5% +$100K
VTV icon
69
Vanguard Morningstar Value ETF
VTV
$189B
$1.81M 0.15%
10,685
GILD icon
70
Gilead Sciences
GILD
$163B
$1.55M 0.13%
16,817
-1,068
-6% -$96.2K
APD icon
71
Air Products & Chemicals
APD
$65.2B
$1.41M 0.12%
4,866
+70
+1% +$22K
ADI icon
72
Analog Devices
ADI
$176B
$1.26M 0.1%
5,934
+47
+0.8% +$10.4K
INTU icon
73
Intuit
INTU
$87.1B
$1.23M 0.1%
1,954
+67
+4% +$42.8K
VXUS icon
74
Vanguard Total International Stock ETF
VXUS
$156B
$1.19M 0.1%
20,230
-200
-1% -$12.4K
ABBV icon
75
AbbVie
ABBV
$433B
$1.15M 0.1%
6,492
-330
-5% -$60.7K

Similar funds

Nixon Peabody Trust's Q4 2024 Portfolio in Review

As of Q4 2024, Nixon Peabody Trust held 152 positions worth $1.21B, up 1.1% from $1.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Nixon Peabody Trust's Q4 2024 filing shows 13 new, 73 increased, 40 reduced and 5 closed positions. Its largest new stake was ASML: 10,257 shares worth $7.11M. The largest sale was Novartis, an estimated $8.45M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.

  • Nixon Peabody Trust's largest Q4 2024 buy was ASML: 10,257 shares worth $7.11M.
  • Nixon Peabody Trust added most to Eli Lilly in Q4 2024, an estimated $6.73M increase.
  • Nixon Peabody Trust's biggest Q4 2024 reduction was Novartis, cutting an estimated $8.45M.
  • Nixon Peabody Trust fully exited A.O. Smith in Q4 2024, selling an estimated $262K.
  • Nixon Peabody Trust's ten largest holdings make up 44% of its $1.21B portfolio in Q4 2024.
  • Nixon Peabody Trust opened 13 new positions and closed 5 in Q4 2024.
  • Nixon Peabody Trust's portfolio value rose 1.1% quarter-over-quarter to $1.21B.

Based on Nixon Peabody Trust's 13F filing for Q4 2024, filed 5 Feb 2025.